Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease
Data from ParkReg covering 150 patients over 3 years show LECIG to be an effective and safe device-aided therapy for advanced PD. However, the long-term efficacy and tolerability of LECIG need to be further investigated.
Authors
- Per Odin (ORCID: https://orcid.org/0000-0002-0756-7478)
- Per Svenningsson (ORCID: https://orcid.org/0000-0001-6727-3802)
- Filip Bergquist (ORCID: https://orcid.org/0000-0002-3437-0267)
- Monica Scharfenort (ORCID: https://orcid.org/0000-0003-4415-1428)
- Nil Dizdar (ORCID: https://orcid.org/0000-0002-9556-6984)
- Dag Nyholm (ORCID: https://orcid.org/0000-0001-9776-7715)
- Ioanna Markaki (ORCID: https://orcid.org/0000-0003-3328-5746)
- Mezin Öthman (ORCID: https://orcid.org/0009-0007-7139-8561)
- Anders Johansson (ORCID: https://orcid.org/0000-0002-3928-5184)
Institutions
- Linköping University (SE)
- Uppsala University (SE)
- Uppsala University Hospital (SE)
- Lund University (SE)
- Sahlgrenska University Hospital (SE)
- Karolinska Institutet (SE)
- Skåne University Hospital (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2024-12-03
- DOI
- https://doi.org/10.1111/ene.16582
- Citations
- 6
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.21